These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 520114)

  • 1. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study.
    Kannel WB; McGee DL
    Diabetes Care; 1979; 2(2):120-6. PubMed ID: 520114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and cardiovascular disease. The Framingham study.
    Kannel WB; McGee DL
    JAMA; 1979 May; 241(19):2035-8. PubMed ID: 430798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, diabetes, and risk of cardiovascular disease in the elderly.
    Wilson PW; Kannel WB
    Am J Geriatr Cardiol; 2002; 11(2):119-23,125. PubMed ID: 11872970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and cardiovascular risk factors: the Framingham study.
    Kannel WB; McGee DL
    Circulation; 1979 Jan; 59(1):8-13. PubMed ID: 758126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is hyperglycemia associated with cardiovascular disease? The Framingham Study.
    Wilson PW; Cupples LA; Kannel WB
    Am Heart J; 1991 Feb; 121(2 Pt 1):586-90. PubMed ID: 1990765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience.
    Kannel WB; D'Agostino RB; Wilson PW; Belanger AJ; Gagnon DR
    Am Heart J; 1990 Sep; 120(3):672-6. PubMed ID: 2389702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study.
    Abbott RD; Brand FN; Kannel WB
    Am J Med; 1990 Apr; 88(4):376-81. PubMed ID: 2327425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen and risk of cardiovascular disease. The Framingham Study.
    Kannel WB; Wolf PA; Castelli WP; D'Agostino RB
    JAMA; 1987 Sep; 258(9):1183-6. PubMed ID: 3626001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults.
    McPhillips JB; Barrett-Connor E; Wingard DL
    Am J Epidemiol; 1990 Mar; 131(3):443-53. PubMed ID: 2301354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Framingham Disability Study: relationship of disability to cardiovascular risk factors among persons free of diagnosed cardiovascular disease.
    Pinsky JL; Branch LG; Jette AM; Haynes SG; Feinleib M; Cornoni-Huntley JC; Bailey KR
    Am J Epidemiol; 1985 Oct; 122(4):644-56. PubMed ID: 3161323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
    Niskanen L; Turpeinen A; Penttilä I; Uusitupa MI
    Diabetes Care; 1998 Nov; 21(11):1861-9. PubMed ID: 9802734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study.
    Brand FN; Abbott RD; Kannel WB
    Diabetes; 1989 Apr; 38(4):504-9. PubMed ID: 2925008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopause and risk of cardiovascular disease: the Framingham study.
    Kannel WB; Hjortland MC; McNamara PM; Gordon T
    Ann Intern Med; 1976 Oct; 85(4):447-52. PubMed ID: 970770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study.
    Howard BV; Cowan LD; Go O; Welty TK; Robbins DC; Lee ET
    Diabetes Care; 1998 Aug; 21(8):1258-65. PubMed ID: 9702430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the female advantage with cardiovascular disease for women with diabetes.
    Leibson C
    Lupus; 1999; 8(5):351-5. PubMed ID: 10455512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study.
    Jager A; van Hinsbergh VW; Kostense PJ; Emeis JJ; Nijpels G; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
    Diabetes; 2000 Mar; 49(3):485-91. PubMed ID: 10868972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events.
    Mak KH; Ma S; Heng D; Tan CE; Tai ES; Topol EJ; Chew SK
    Am J Cardiol; 2007 Jul; 100(2):227-33. PubMed ID: 17631075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetes and its cardiovascular complications. Research acquisitions in Malta].
    Zammit Maempel JV
    Minerva Med; 1972 May; 63(39):2229-36. PubMed ID: 5035393
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance.
    Marchesini G; Ronchi M; Forlani G; Bugianesi E; Bianchi G; Fabbri A; Zoli M; Melchionda N
    Am J Gastroenterol; 1999 Mar; 94(3):655-62. PubMed ID: 10086647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.